These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33953173)

  • 1. Cohesin-protein Shugoshin-1 controls cardiac automaticity via HCN4 pacemaker channel.
    Liu D; Song AT; Qi X; van Vliet PP; Xiao J; Xiong F; Andelfinger G; Nattel S
    Nat Commun; 2021 May; 12(1):2551. PubMed ID: 33953173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of pacing function by HCN4 overexpression in human pluripotent stem cell-derived cardiomyocytes.
    Saito Y; Nakamura K; Yoshida M; Sugiyama H; Akagi S; Miyoshi T; Morita H; Ito H
    Stem Cell Res Ther; 2022 Apr; 13(1):141. PubMed ID: 35365232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-associated HCN4 V759I variant is not sufficient to impair cardiac pacemaking.
    Erlenhardt N; Kletke O; Wohlfarth F; Komadowski MA; Clasen L; Makimoto H; Rinné S; Kelm M; Jungen C; Decher N; Meyer C; Klöcker N
    Pflugers Arch; 2020 Dec; 472(12):1733-1742. PubMed ID: 33095298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expanding phenotypes of cohesinopathies: one ring to rule them all!
    Piché J; Van Vliet PP; Pucéat M; Andelfinger G
    Cell Cycle; 2019 Nov; 18(21):2828-2848. PubMed ID: 31516082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Subtypes Classified by Electrophysiology.
    Yechikov S; Copaciu R; Gluck JM; Deng W; Chiamvimonvat N; Chan JW; Lieu DK
    Stem Cells; 2016 Nov; 34(11):2670-2680. PubMed ID: 27434649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1-mediated histone demethylation of HCN4 contributes to aconitine-induced ventricular myocardial dysrhythmia.
    Zhou W; Qiu LZ; Liu H; Deng HF; Yue LX; Gao Y
    Toxicol Lett; 2020 Jul; 327():19-31. PubMed ID: 32234357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac arrhythmia induced by genetic silencing of 'funny' (f) channels is rescued by GIRK4 inactivation.
    Mesirca P; Alig J; Torrente AG; Müller JC; Marger L; Rollin A; Marquilly C; Vincent A; Dubel S; Bidaud I; Fernandez A; Seniuk A; Engeland B; Singh J; Miquerol L; Ehmke H; Eschenhagen T; Nargeot J; Wickman K; Isbrandt D; Mangoni ME
    Nat Commun; 2014 Aug; 5():4664. PubMed ID: 25144323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cells.
    Darche FF; Rivinius R; Köllensperger E; Leimer U; Germann G; Seckinger A; Hose D; Schröter J; Bruehl C; Draguhn A; Gabriel R; Schmidt M; Koenen M; Thomas D; Katus HA; Schweizer PA
    Life Sci; 2019 Sep; 232():116620. PubMed ID: 31291594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional control of pacemaker channel genes HCN2 and HCN4 by Sp1 and implications in re-expression of these genes in hypertrophied myocytes.
    Lin H; Xiao J; Luo X; Chen G; Wang Z
    Cell Physiol Biochem; 2009; 23(4-6):317-26. PubMed ID: 19471099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-induced inhibition of cardiac pacemaker channel HCN4 triggers bradycardia in human-induced stem cell system.
    Peischard S; Möller M; Disse P; Ho HT; Verkerk AO; Strutz-Seebohm N; Budde T; Meuth SG; Schweizer PA; Morris S; Mücher L; Eisner V; Thomas D; Klingel K; Busch K; Seebohm G
    Cell Mol Life Sci; 2022 Jul; 79(8):440. PubMed ID: 35864219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker.
    Saito Y; Nakamura K; Yoshida M; Sugiyama H; Ohe T; Kurokawa J; Furukawa T; Takano M; Nagase S; Morita H; Kusano KF; Ito H
    PLoS One; 2015; 10(9):e0138193. PubMed ID: 26384234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Analyses of Novel HCN4 Gene Mutations.
    Möller M; Silbernagel N; Wrobel E; Stallmayer B; Amedonu E; Rinné S; Peischard S; Meuth SG; Wünsch B; Strutz-Seebohm N; Decher N; Schulze-Bahr E; Seebohm G
    Cell Physiol Biochem; 2018; 49(3):1197-1207. PubMed ID: 30196304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting miR-423-5p Reverses Exercise Training-Induced HCN4 Channel Remodeling and Sinus Bradycardia.
    D'Souza A; Pearman CM; Wang Y; Nakao S; Logantha SJRJ; Cox C; Bennett H; Zhang Y; Johnsen AB; Linscheid N; Poulsen PC; Elliott J; Coulson J; McPhee J; Robertson A; da Costa Martins PA; Kitmitto A; Wisløff U; Cartwright EJ; Monfredi O; Lundby A; Dobrzynski H; Oceandy D; Morris GM; Boyett MR
    Circ Res; 2017 Oct; 121(9):1058-1068. PubMed ID: 28821541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associated changes in HCN2 and HCN4 transcripts and I(f) pacemaker current in myocytes.
    Zhang Q; Huang A; Lin YC; Yu HG
    Biochim Biophys Acta; 2009 May; 1788(5):1138-47. PubMed ID: 19236845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart.
    Stieber J; Herrmann S; Feil S; Löster J; Feil R; Biel M; Hofmann F; Ludwig A
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15235-40. PubMed ID: 14657344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation in S6 domain of HCN4 channel in patient with suspected Brugada syndrome modifies channel function.
    Biel S; Aquila M; Hertel B; Berthold A; Neumann T; DiFrancesco D; Moroni A; Thiel G; Kauferstein S
    Pflugers Arch; 2016 Oct; 468(10):1663-71. PubMed ID: 27553229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Small Non-Coding MicroRNAs Controlling Pacemaker Mechanisms in the Human Sinus Node.
    Petkova M; Atkinson AJ; Yanni J; Stuart L; Aminu AJ; Ivanova AD; Pustovit KB; Geragthy C; Feather A; Li N; Zhang Y; Oceandy D; Perde F; Molenaar P; D'Souza A; Fedorov VV; Dobrzynski H
    J Am Heart Assoc; 2020 Oct; 9(20):e016590. PubMed ID: 33059532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering physiologically controlled pacemaker cells with lentiviral HCN4 gene transfer.
    Boink GJ; Verkerk AO; van Amersfoorth SC; Tasseron SJ; van der Rijt R; Bakker D; Linnenbank AC; van der Meulen J; de Bakker JM; Seppen J; Tan HL
    J Gene Med; 2008 May; 10(5):487-97. PubMed ID: 18383475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic dinucleotides bind the C-linker of HCN4 to control channel cAMP responsiveness.
    Lolicato M; Bucchi A; Arrigoni C; Zucca S; Nardini M; Schroeder I; Simmons K; Aquila M; DiFrancesco D; Bolognesi M; Schwede F; Kashin D; Fishwick CW; Johnson AP; Thiel G; Moroni A
    Nat Chem Biol; 2014 Jun; 10(6):457-62. PubMed ID: 24776929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.
    Ueda K; Nakamura K; Hayashi T; Inagaki N; Takahashi M; Arimura T; Morita H; Higashiuesato Y; Hirano Y; Yasunami M; Takishita S; Yamashina A; Ohe T; Sunamori M; Hiraoka M; Kimura A
    J Biol Chem; 2004 Jun; 279(26):27194-8. PubMed ID: 15123648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.